PROVIDER PROFILE · NPI 1356500011
Hyland CroninM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
6,245
Unique beneficiaries
—
Total services
9,417
Distinct HCPCS
36
Medicare payment
$1.4M
Peer benchmark
Total Medicare services vs. 262 Dermatology providers in MD — top quintile (cohort median 2,654).
PRESCRIBING · PART D · 2024
Total Rx claims
2,454
Beneficiaries
—
Total drug cost
$59K
Distinct drugs
24
Brand share
4.2%
Top prescribed drugs
Mupirocin938 claims
Cefadroxil429 claims
Clobetasol Propionate237 claims
Silver Sulfadiazine119 claims
Triamcinolone Acetonide114 claims
QUALITY · MIPS · 2024
Final MIPS score
98.2
Quality
96.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.97%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$524
Payment records
23
By payment type
Food and Beverage$524
Top paying entities
Food and Beverage$524
REFERRAL NETWORK
Where Hyland Cronin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Annapath, Inc Clinical Laboratory · Bowie, MD | 46 | 116 |
| SHORE HEALTH SYSTEM, INC | 45 | 151 |
| AMERIPATH NEW YORK LLC | 19 | 23 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 18 | 36 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| SHORE HEALTH SYSTEM, INC | 39 | 159 |
| Annapath, Inc Clinical Laboratory · Bowie, MD | 27 | 125 |
| Michael Del Torto Dermatology · Easton, MD | 20 | 72 |
| Donald Stranahan Dermatology · Easton, MD | 15 | 41 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 13 | 31 |
| Rishi Patel Dermatology · Brooksville, FL | 11 | 12 |
| SHORE HEALTH SYSTEM, INC | 11 | 49 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE